ESC Premium Access

Long-term outcomes after medical therapy, alcohol septal ablation, and myectomy in patients with hypertrophic obstructive cardiomyopathy

Presentation

About the speaker

Doctor Shanshan Zhai

Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (China)
0 follower

4 more presentations in this session

State of the art in risk stratification in hypertrophic cardiomyopathy.

Speaker: Doctor P. Spirito (Monza, IT)

Thumbnail

Association of global extracellular volume and late gadolinium enhancement with the estimated 5 year risk of sudden cardiac death according to HCM risk-SCD score in hypertrophic cardiomyopathy

Speaker: Doctor J. Muench (Hamburg, DE)

Thumbnail

Comparison of linear versus cubic assessment of left atrial size in the prediction of atrial fibrillation development in hypertrophic cardiomyopathy

Speaker: Doctor A. Giamundo (Naples, IT)

Thumbnail

Future direction for research in sudden death prediction in hypertrophic cardiomyopathy .

Speaker: Professor P. Elliott (London, GB)

Thumbnail

Access the full session

Risk stratification in hypertrophic cardiomyopathy

Speakers: Doctor S. Zhai, Doctor P. Spirito, Doctor J. Muench, Doctor A. Giamundo, Professor P. Elliott
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

Related content

Open Access

Imaging in diagnosing hypertrophic obstructive cardiomyopathy.

30 August 2021

ESC Premium Access

More facets of acute myocarditis.

27 August 2021

ESC Premium Access

The HEP-COVID Trial

27 August 2021

This platform is supported by

logo Novo Nordisk